Skip to content

13F-HR filed by Velan Capital Investment Management LP

Velan Capital Investment Management LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-13, with 29 holding rows worth $123,989,329.

Accession
0001848809-23-000004
Filed
2023-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2023

A holdings report, 30 entries on the cover page, a total value of $123,989,329 stated on the cover page (in dollars after the unit check, H1), rows summing to $123,989,329 with VALUE read as dollars as filed, 13F file number 028-21996. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALIMERA SCIENCES INC016259202COM13,608,533$42,186,452dollars as filed
PRAXIS PRECISION MEDICINES I74006W108COM5,185,000$8,866,350dollars as filed
JASPER THERAPEUTICS INC471871103COM11,219,036$7,586,797dollars as filed
HERON THERAPEUTICS INC427746102COM6,986,744$7,196,346dollars as filed
ADMA BIOLOGICS INC000899104COM1,736,100$6,215,238dollars as filed
TELA BIO INC872381108COM746,087$5,968,696dollars as filed
QUIPT HOME MEDICAL CORP74880P104COM1,100,000$5,599,000dollars as filed
LANTHEUS HLDGS INC516544103COM75,000$5,211,000dollars as filed
OPTINOSE INC68404V100COM3,596,861$4,424,139dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock55,300$3,152,100dollars as filed
INSPIRE MED SYS INC COM457730109Stock15,300$3,036,132dollars as filed
IMMUNOGEN INC45253H101COMMON STOCK189,500$3,007,365dollars as filed
INSPIREMD INC45779A846COM904,029$2,956,175dollars as filed
GOSSAMER BIO INC COM38341P102Stock3,065,136$2,552,645dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK150,000$2,283,000dollars as filed
APELLIS PHARMACEUTICALS INC03753U106COM50,000$1,902,000dollars as filed
GERON CORP374163103COM778,500$1,650,420dollars as filed
TENET HEALTHCARE CORP COM NEW88033G407Stock24,937$1,643,099dollars as filed
ICOSAVAX INC45114M109COM160,630$1,244,883dollars as filed
ASLAN PHARMACEUTICALS LTD04522R200SPON ADS NEW625,000$1,175,000dollars as filed
IOVANCE BIOTHERAPEUTICS INC462260100COM250,000$1,137,500dollars as filedcall
ANNEXON INC03589W102COM459,746$1,085,001dollars as filed
EDESA BIOTECH INC27966L108COM1,281,615$809,981dollars as filed
CULLINAN THERAPEUTICS INC230031106COM75,000$678,750dollars as filed
Inflarx NvN44821101COM200,000$596,000dollars as filed
REZOLUTE INC76200L309COMMON STOCK400,000$528,000dollars as filed
QUIPT HOME MEDICAL CORP74880P104COM100,000$509,000dollars as filedcall
INHIBRX INC45720L107COM25,000$458,750dollars as filed
ELEVATION ONCOLOGY INC COM28623U101Stock497,299$329,510dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001848809-23-000004this filing2023-11-13acceptance time not in the bulk data set